Men's Health

What Causes Low Libido with PMS?

Low libido during the premenstrual phase affects up to 40% of women with PMS, yet it's rarely treated as a distinct symptom with identifiable, testable causes. Hormonal shifts in the luteal phase, elevated cortisol, and micronutrient depletion all converge to suppress desire — and each requires a different fix.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
PMS libidolow libido PMSluteal phase hormonestestosterone womencortisol and libidoPMS supplements
What Causes Low Libido with PMS?

What Causes Low Libido with PMS?

Low libido with PMS is real, measurable, and driven by at least three overlapping biological mechanisms: a sharp luteal-phase drop in estrogen and testosterone, rising cortisol that suppresses the HPG axis, and nutrient deficits — particularly zinc and magnesium — that blunt androgen signaling. The main caveat is that severity tracks closely with how pronounced your hormonal swing is; women with PMDD experience significantly greater libido suppression than those with mild PMS. If libido loss is the only symptom and you have no luteal-phase mood or energy changes, a non-hormonal driver such as thyroid dysfunction or iron deficiency is worth ruling out first.

---

Why the Luteal Phase Tanks Desire

Libido in women is not estrogen-only territory. Free testosterone — produced in the ovaries and adrenal glands — is the primary androgenic driver of sexual desire, and its availability fluctuates across the menstrual cycle. Testosterone peaks near ovulation, then declines sharply as progesterone dominates the mid-to-late luteal phase. By days 24–28, free testosterone can be 30–40% lower than at ovulation (Davison & Davis, Journal of Sexual Medicine 2012; PMID: 22757743).

At the same time, progesterone metabolizes into allopregnanolone — a neuroactive steroid that modulates GABA-A receptors and has a sedating, libido-dampening effect in some women. The same compound that calms anxiety in some people reduces motivational drive and sexual interest in others, depending on receptor sensitivity (Bäckström et al., Progress in Neurobiology 2014; PMID: 24239930).

Estrogen, which briefly peaks before ovulation, is also declining through the late luteal phase. Since estrogen upregulates oxytocin receptors and vaginal tissue sensitivity, its drop contributes to reduced physical arousal as well as psychological desire. This dual decline — both androgens and estrogen falling simultaneously — creates the classic PMS libido valley.

---

How Cortisol and Chronic Stress Suppress Luteal-Phase Libido

Cortisol and testosterone share an inverse relationship mediated through the hypothalamic-pituitary-gonadal (HPG) axis. Elevated cortisol suppresses GnRH pulsatility, which reduces LH output, which in turn reduces ovarian testosterone synthesis. In women with PMS, cortisol reactivity during the luteal phase is measurably higher than in women without PMS (Girdler et al., Biological Psychology 2007; PMID: 17524558).

This is why many women report that stress makes PMS — including libido loss — dramatically worse. It's not psychosomatic: the HPA-HPG axis crosstalk is a documented physiological pathway. When cortisol is chronically elevated through work demands, poor sleep, or caloric restriction, the body effectively treats reproduction as a non-essential function and downregulates desire at the neurological and hormonal level simultaneously.

For practical context, this means that if you are managing stress poorly in the follicular phase, the cortisol burden compounds by the time you reach day 21–28, arriving in the luteal phase already hormonally compromised. If stress-driven libido changes resonate with you, the deeper context on hormonal, nutritional, and stress drivers of low libido is worth reading alongside this article.

Insomnia is another cortisol amplifier. Poor luteal-phase sleep elevates cortisol the following day, creating a feedback loop that deepens both the hormonal and psychological dimensions of low desire. This pattern is covered in detail in what causes insomnia with PMS.

---

Hormonal imbalance gets most of the attention, but micronutrient status is a meaningful modulator of libido during the luteal phase. Three stand out:

Zinc

Zinc is required for testosterone synthesis and for the activity of 5-alpha reductase, the enzyme that converts testosterone to its more potent form. Low zinc is associated with reduced testosterone in both men and women (Prasad et al., Nutrition 1996; PMID: 8875519). Premenstrual zinc depletion has been documented — zinc levels drop measurably in the late luteal phase, and supplementation has been shown in randomized trials to reduce PMS severity scores (Jafari et al., Biological Trace Element Research 2020; PMID: 32030565).

Magnesium

Magnesium deficiency dysregulates the HPA axis, raising baseline cortisol. It also reduces the activity of sex hormone-binding globulin (SHBG) indirectly, meaning that low magnesium can alter the balance between bound and free testosterone. Several trials have found that magnesium supplementation in the luteal phase reduces PMS symptoms including mood changes and cramping, though libido was not always a primary endpoint.

Vitamin B6

B6 is required for dopamine synthesis. Dopamine is the neurotransmitter most closely linked to motivation and sexual drive — it is not the hormone itself but the signal that makes you want to act on desire. Low B6 reduces dopaminergic tone, blunting motivation broadly, including libido. B6 supplementation has shown modest PMS benefit in several trials, particularly for mood and irritability symptoms.

---

Biomarkers Worth Testing Before You Supplement

Treating low PMS libido without knowing your baseline is a guessing game. The following panel gives you actionable data:

BiomarkerWhy It MattersOptimal Range (Women, Luteal)
Free TestosteronePrimary androgenic driver of desire1.0–2.2 pg/mL (varies by lab)
Total TestosteroneOverall androgen burden15–70 ng/dL
SHBGBinds testosterone, reducing free fraction20–130 nmol/L (lower is better for libido)
Cortisol (AM serum or 4-point saliva)HPA axis dysregulationSaliva: pattern matters more than single value
Progesterone (Day 21)Confirms luteal adequacy>5 ng/mL confirms ovulation
EstradiolContextualizes the estrogen-progesterone ratio50–200 pg/mL mid-luteal
Zinc (serum)Androgen synthesis cofactor70–120 mcg/dL
Magnesium (RBC, not serum)More accurate tissue status4.2–6.8 mg/dL
Thyroid (TSH, Free T3, Free T4)Thyroid dysfunction mimics PMS libido lossTSH: 0.5–2.5 mIU/L optimal

Thyroid function deserves special mention. Hypothyroidism and PMS share overlapping symptoms — fatigue, low libido, mood changes — and subclinical hypothyroidism is frequently missed when only TSH is tested. If you experience low libido with low energy and cold intolerance, reading about low libido in perimenopause with hypothyroidism can clarify whether thyroid involvement is likely even at younger ages.

---

Low Testosterone Root Causes Beyond the Menstrual Cycle

While the luteal-phase hormonal swing is the most proximate cause of PMS-related libido loss, persistent low testosterone between cycles is a separate problem that amplifies the premenstrual dip. The most common underlying drivers:

  • PCOS: Paradoxically, while PCOS raises total testosterone in many cases, it also elevates SHBG in some phenotypes and disrupts the ratio of free to bound testosterone. Libido is often low despite elevated androgens. The specific mechanisms are covered in what causes low libido in PCOS.
  • Adrenal insufficiency or chronic adrenal fatigue: The adrenal glands contribute roughly 50% of female testosterone via DHEA-S conversion. Adrenal insufficiency or chronic HPA axis dysregulation reduces this contribution significantly.
  • Caloric restriction and low body fat: The HPG axis is highly sensitive to energy availability. Women in a significant caloric deficit or with very low body fat (below ~17%) often have suppressed LH pulsatility and reduced testosterone synthesis.
  • Oral contraceptive use: Combined OCP increases SHBG dramatically, binding free testosterone and reducing its availability. Women on the OCP who experience persistent low libido should discuss SHBG levels with their clinician.
  • Elevated prolactin: Hyperprolactinemia suppresses GnRH and reduces testosterone. This is worth testing if libido loss is accompanied by galactorrhea or menstrual irregularity.

---

This is not a substitute for clinical evaluation, but a prioritized framework based on the evidence:

  1. Test first: Run the biomarker panel above, ideally on day 21 of your cycle for luteal hormones. Don't supplement hormones without baseline data.
  2. Address sleep: Cortisol dysregulation is both a cause and consequence of poor luteal-phase sleep. Prioritize sleep hygiene during days 18–28. See what causes waking at 3am with PMS for the cortisol-awakening connection.
  3. Correct nutrient gaps: If zinc or magnesium is suboptimal on testing, replete before adding hormonal interventions. Zinc at 15–30 mg elemental and magnesium glycinate at 200–400 mg are standard clinical starting doses.
  4. Support adrenal function: Adaptogenic herbs like Rhodiola rosea have evidence for cortisol modulation in stressed adults (Olsson et al., Planta Medica 2009; PMID: 19016404). Ashwagandha (KSM-66, 600 mg/day) has demonstrated reductions in serum cortisol of up to 27% in 60-day RCTs (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798).
  5. Reduce SHBG if elevated: Vitamin D deficiency is associated with elevated SHBG; correcting D3 status can modestly improve free testosterone availability.
  6. Discuss DHEA with your clinician: If free testosterone is low and DHEA-S is in the lower quartile, low-dose DHEA (10–25 mg) has evidence for improving female libido in some populations.

---

What This Means for Your Formula

If blood work or wearable data suggests HPA axis dysregulation, low zinc, suboptimal vitamin D, or blunted androgen signaling, Ones can incorporate evidence-based ingredients to target the specific drivers:

  • Ashwagandha (KSM-66, 600 mg): Ones uses the clinically studied KSM-66 extract at the full 600 mg dose used in cortisol and stress trials. For women whose libido loss is driven primarily by elevated cortisol suppressing the HPG axis, this is one of the most direct nutritional interventions available.
  • Zinc (bisglycinate form): Ones includes zinc at doses calibrated to your bloodwork, using bisglycinate for superior absorption and GI tolerance compared to zinc sulfate. Given the documented luteal-phase drop in zinc, this is often a high-priority inclusion for women with PMS-related hormonal symptoms.
  • Rhodiola Rosea: For women with stress-amplified luteal symptoms, Rhodiola supports cortisol regulation and dopaminergic tone — addressing both the hormonal suppression pathway and the motivational-drive component of libido.

Ones does not prescribe hormones or replace clinical care. What it does is ensure you're not losing ground to correctable nutrient gaps while your healthcare provider addresses any hormonal layer.

---

Key Takeaways

  • Low libido with PMS is primarily caused by late-luteal drops in free testosterone and estrogen, compounded by rising progesterone's neuroactive effects and elevated cortisol suppressing the HPG axis.
  • Chronic stress is not just psychological — it has a documented physiological pathway (HPA-HPG crosstalk) that directly reduces testosterone synthesis.
  • Zinc, magnesium, and vitamin B6 are the most evidence-supported micronutrients for PMS-related libido and hormone regulation; test before you supplement.
  • A day-21 luteal panel (free testosterone, SHBG, progesterone, cortisol, estradiol) gives you the data needed to target the right intervention — not all PMS libido loss has the same root cause.
  • Ashwagandha KSM-66 at 600 mg/day has RCT evidence for reducing cortisol up to 27%, making it one of the most mechanistically relevant adaptogens for stress-driven PMS libido suppression.
  • If libido loss persists outside the luteal phase, rule out hypothyroidism, hyperprolactinemia, OCP-elevated SHBG, and adrenal insufficiency before attributing it to PMS alone.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading